6533b81ffe1ef96bd127701d

RESEARCH PRODUCT

MP-03.04 The Combination Treatment of Bicalutamide Plus Carbidopa Significantly Enhances the in vivo Antitumor Activity on LNCaP Castration-resistant Prostate Cancer Xenograft Tumors Compared To Single Use of Each Drug

Ladan FazliMartin E. GleaveChristian ThomasChristian ThomasP S RennieLatif A. WafaFrancois Lamoureux

subject

Antitumor activityOncologyDrugmedicine.medical_specialtyBicalutamidebusiness.industryUrologymedia_common.quotation_subjectmedicine.diseaseProstate cancerIn vivoInternal medicineCarbidopaLNCaPmedicineCancer researchbusinessTumor xenograftmedicine.drugmedia_commonhttps://doi.org/10.1016/j.urology.2011.07.053